skip to main content
Idioma:
Primo Advanced Search
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search Query Term
Primo Advanced Search prefilters
Busca Simples
Resultados 1 2 3 4 5 next page
Mostrar Somente
Refinado por: tipo de recurso: Anais de Congresso remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study
LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

LBA46 Bevacizumab (B) plus FOLFIRI after failure of platinum-etoposide in patients (pts) with advanced neuroendocrine carcinoma (NEC): The PRODIGE 41-BEVANEC randomized phase II study

Walter, T.A. ; Lievre, A. ; Coriat, R. ; Malka, D. ; El Hajbi, F. ; Di Fiore, F. ; Dhome, O. Hentic ; Smith, D. ; Hautefeuille, V. ; Roquin, G. ; Perrier, M. ; Dahan, L. ; V. Granger ; Sobhani, I. ; Mineur, L. ; Niccoli, P. ; Assenat, E. ; Le Malicot, K. ; Lepage, C. ; Bohas, C. Lombard

Annals of oncology, 2022, Vol.33, p.S1412 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
2
Weekly Etoposide and Platinum in Small-Cell Lung Cancer: Hope and Scope for Fragile Patients
Weekly Etoposide and Platinum in Small-Cell Lung Cancer: Hope and Scope for Fragile Patients
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Weekly Etoposide and Platinum in Small-Cell Lung Cancer: Hope and Scope for Fragile Patients

Sundriyal, Deepak ; Kumar, Parmod ; Gogisetti, Yeswanth ; Sehrawat, Amit

Indian Journal of Medical and Paediatric Oncology, 2021, Vol.42 (2) [Periódico revisado por pares]

A-12, 2nd Floor, Sector 2, Noida-201301 UP, India: Thieme Medical and Scientific Publishers Pvt. Ltd

Texto completo disponível

Citações Citado por
3
The ABC-study: A randomized phase III study comparing one course of adjuvant bleomycin, etoposide, and cisplatin (BEP) and one course of carboplatin AUC7 in clinical stage I seminomatous testicular cancer
The ABC-study: A randomized phase III study comparing one course of adjuvant bleomycin, etoposide, and cisplatin (BEP) and one course of carboplatin AUC7 in clinical stage I seminomatous testicular cancer
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

The ABC-study: A randomized phase III study comparing one course of adjuvant bleomycin, etoposide, and cisplatin (BEP) and one course of carboplatin AUC7 in clinical stage I seminomatous testicular cancer

Tandstad, Torgrim ; Stahl, Olof ; Dahl, Olav ; Glimelius, Ingrid ; Haugnes, Hege Sagstuen ; Karlsdottir, Asa ; Langberg, Carl Wilhelm ; Soderstrom, Karin ; Solberg, Arne ; Stierner, Ulrika K. ; Wall, Najme ; Cohn-Cedermark, Gabriella Elisabeth

JOURNAL OF CLINICAL ONCOLOGY, 2017, Vol.35 (15_suppl), p.TPS4593-TPS4593 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
4
Durvalumab+ Tremelimumab + Platin-Etoposide in first-line extensive-stage SCLC (ES-SCLC): 36-month Overall Survival from the Phase 3 CASPIAN study
Durvalumab+ Tremelimumab + Platin-Etoposide in first-line extensive-stage SCLC (ES-SCLC): 36-month Overall Survival from the Phase 3 CASPIAN study
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Durvalumab+ Tremelimumab + Platin-Etoposide in first-line extensive-stage SCLC (ES-SCLC): 36-month Overall Survival from the Phase 3 CASPIAN study

Bischoff, H ; Paz-Ares, L ; Chen, Y ; Reinmuth, N ; Hotta, K ; Trukhin, D ; Statsenko, G ; Hochmair, M J ; Özgüroğlu, M ; Li, J H ; Voitko, O ; Poltoratskiy, A ; Verderame, F ; Havel, L ; Bondarenko, I ; Losonczy, G ; Conev, N ; Broadhurst, H ; Dalvi, T ; Jiang, H ; Golgman, J W ; Alt, J

Pneumologie, 2022, Vol.76 (S 01) [Periódico revisado por pares]

Rüdigerstraße 14, 70469 Stuttgart, Germany: Georg Thieme Verlag

Texto completo disponível

Citações Citado por
5
Analysis of stably expressed genes with low-dose etoposide for toxicological studies in osteosarcoma
Analysis of stably expressed genes with low-dose etoposide for toxicological studies in osteosarcoma
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Analysis of stably expressed genes with low-dose etoposide for toxicological studies in osteosarcoma

Ferreira de Oliveira, JMP ; Almeida, L ; Pimentel, F ; Van Zoelen, EJJ ; Santos, C

Planta Medica, 2014, Vol.80 (16) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
6
Cytotoxic effects of ethyl acetate extract of Sambucus ebulus compared with Etoposide on normal and cancer cell lines
Cytotoxic effects of ethyl acetate extract of Sambucus ebulus compared with Etoposide on normal and cancer cell lines
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Cytotoxic effects of ethyl acetate extract of Sambucus ebulus compared with Etoposide on normal and cancer cell lines

Saeedi Saravi, SS ; Shokrzadeh, M ; Mirzayi, M

Planta Medica, 2009, Vol.75 (9) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
An integrated analysis of genome-wide DNA methylation and genetic variants underlying etoposide-induced cytotoxicity in European and African populations
An integrated analysis of genome-wide DNA methylation and genetic variants underlying etoposide-induced cytotoxicity in European and African populations
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

An integrated analysis of genome-wide DNA methylation and genetic variants underlying etoposide-induced cytotoxicity in European and African populations

Li, Ruowang ; Kim, Dokyoon ; Dudek, Scott M. ; Ritchie, Marylyn D.

Applications of Evolutionary Computation, p.928-938 [Periódico revisado por pares]

Berlin, Heidelberg: Springer Berlin Heidelberg

Texto completo disponível

Citações Citado por
8
Naked mole rat cells display more efficient DNA excision repair and higher resistance to toxic impacts than mouse cells
Naked mole rat cells display more efficient DNA excision repair and higher resistance to toxic impacts than mouse cells
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Naked mole rat cells display more efficient DNA excision repair and higher resistance to toxic impacts than mouse cells

Evdokimov, Alexey ; Petruseva, Irina ; Popov, Aleksei ; Koval, Olga ; Lavrik, Olga Bazarnyi, V. ; Kovtun, O.

BIO Web of Conferences, 2020, Vol.22, p.1017 [Periódico revisado por pares]

Les Ulis: EDP Sciences

Texto completo disponível

Citações Citado por
9
Phase II Studie zur simultanen Radiochemotherapie mit Cisplatin/Etoposide gefolgt von einer Erhaltungschemotherapie mit Platin/Gemcitabine bei nicht-resektablem nicht-kleinzelligem Bronchialkarzinom (NSCLC)
Phase II Studie zur simultanen Radiochemotherapie mit Cisplatin/Etoposide gefolgt von einer Erhaltungschemotherapie mit Platin/Gemcitabine bei nicht-resektablem nicht-kleinzelligem Bronchialkarzinom (NSCLC)
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Phase II Studie zur simultanen Radiochemotherapie mit Cisplatin/Etoposide gefolgt von einer Erhaltungschemotherapie mit Platin/Gemcitabine bei nicht-resektablem nicht-kleinzelligem Bronchialkarzinom (NSCLC)

Fink, T ; Melzner, W ; Strnad, V ; Sauer, R ; Birkenhake, S ; Ficker, J

Pneumologie, 2006, Vol.60 (S 1) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Randomized Phase III second-line trial: Topotecan (TM) vs. Topotecan/Etoposide (TE), vs. Topotecan/Gemcitabine (TG) for patients (pts) with relapsed ovarian cancer (ROC)
Randomized Phase III second-line trial: Topotecan (TM) vs. Topotecan/Etoposide (TE), vs. Topotecan/Gemcitabine (TG) for patients (pts) with relapsed ovarian cancer (ROC)
Material Type:
Ata de Congresso 		Adicionar ao Meu Espaço

Randomized Phase III second-line trial: Topotecan (TM) vs. Topotecan/Etoposide (TE), vs. Topotecan/Gemcitabine (TG) for patients (pts) with relapsed ovarian cancer (ROC)

Sehouli, J ; Sommer, H ; Klare, P ; Hindenburg, HJ ; Camara, O ; Lichtenegger, W

Geburtshilfe und Frauenheilkunde, 2006, Vol.66 (S 01) [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Mostrar Somente

  1. Revistas revisadas por pares (182)

Data de Publicação 

De até
Refinar
  1. Antes de1995  (6)
  2. 1995Até2001  (29)
  3. 2002Até2007  (44)
  4. 2008Até2014  (78)
  5. Após 2014  (58)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (127)
  2. Alemão  (79)
  3. Japonês  (16)
  4. Francês  (5)
  5. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.